RMFEX
Price
$60.79
Change
+$0.27 (+0.45%)
Updated
Jul 25 closing price
Net Assets
110.54B
VGICX
Price
$72.23
Change
+$0.25 (+0.35%)
Updated
Jul 25 closing price
Net Assets
6.51B
Interact to see
Advertisement

RMFEX vs VGICX

Header iconRMFEX vs VGICX Comparison
Open Charts RMFEX vs VGICXBanner chart's image
American Funds American Mutual R4
Price$60.79
Change+$0.27 (+0.45%)
VolumeN/A
Net Assets110.54B
JPMorgan US Value C
Price$72.23
Change+$0.25 (+0.35%)
VolumeN/A
Net Assets6.51B
RMFEX vs VGICX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RMFEX vs. VGICX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RMFEX is a Buy and VGICX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFEX has more cash in the bank: 111B vs. VGICX (6.51B). RMFEX pays higher dividends than VGICX: RMFEX (1.53) vs VGICX (0.90). RMFEX was incepted earlier than VGICX: RMFEX (23 years) vs VGICX (28 years). VGICX (1.50) is less costly to investors than RMFEX (0.62). RMFEX is a more actively managed with annual turnover of: 31.00 vs. VGICX (18.00). RMFEX has a lower initial minimum investment than VGICX: RMFEX (250) vs VGICX (1000). RMFEX annual gain was more profitable for investors over the last year : 11.74 vs. VGICX (9.06). VGICX return over 5 years is better than : 78.01 vs. RMFEX (62.99).
RMFEXVGICXRMFEX / VGICX
Total Expense Ratio0.621.4443%
Annual Report Gross Expense Ratio0.621.5041%
Fund Existence23 years28 years-
Gain YTD11.5276.815169%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets111B6.51B1,705%
Annual Yield % from dividends1.530.90171%
Returns for 1 year11.749.06130%
Returns for 3 years32.0836.1189%
Returns for 5 years62.9978.0181%
Returns for 10 years88.9686.28103%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BEAM21.720.77
+3.68%
Beam Therapeutics
ESPR1.510.02
+1.34%
Esperion Therapeutics
BMRN59.01-0.75
-1.26%
BioMarin Pharmaceutical
TOUR0.86-0.02
-2.16%
Tuniu Corp
IMTE1.15-0.11
-8.73%
Integrated Media Technology Limited